Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 13 Similar Profiles
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
B-Cell Lymphoma Medicine & Life Sciences
Follicular Lymphoma Medicine & Life Sciences
B-Lymphocytes Medicine & Life Sciences
Survival Medicine & Life Sciences
Lymphoma Medicine & Life Sciences
Cells Chemical Compounds
Mantle-Cell Lymphoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2008 2016

Molecular Diagnosis and Prognosis in Aggressive Lymphoma

Rimsza, L. M.

National Institutes of Health

8/1/117/31/16

Project: Research projectResearch Project--Cooperative Agreements

Lymphoma
Paraffin
Formaldehyde
Leukemia
Nuclease Protection Assays

SPORE in Lymphoma

Rimsza, L. M., Land, H., Friedberg, J., Fisher, S., Mahadevan, D., Peterson, D. R., Bernstein, S., Jordan, C. T. & Fisher, R.

National Institutes of Health

9/1/088/31/14

Project: Research projectSpecialized Center

Translational Medical Research
Lymphoma
Research Ethics Committees
Cell Line
Cataloging

Research Output 1985 2018

  • 14690 Citations
  • 54 h-Index
  • 159 Article
  • 3 Letter
  • 2 Chapter
  • 2 Review article

A phase I/II trial of vorinostat (SAHA) in combination with rituximab-CHOP in patients with newly diagnosed advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0806

Persky, D. O., Li, H., Rimsza, L. M., Barr, P. M., Popplewell, L. L., Bane, C. L., Von Gehr, A., LeBlanc, M., Fisher, R. I., Smith, S. M. & Friedberg, J. W. Apr 1 2018 In : American Journal of Hematology. 93, 4, p. 486-493 8 p.

Research output: Contribution to journalArticle

Histocompatibility
Histone Deacetylase Inhibitors
Lymphoma, Large B-Cell, Diffuse
Disease-Free Survival
Febrile Neutropenia

Continued excellent outcomes in previously untreated patients with follicular lymphoma after treatment with CHOP plus rituximab or CHOP plus 131I-Tositumomab: Long-Term follow-up of phase III randomized study SWOG-S0016

Shadman, M., Li, H., Rimsza, L., Leonard, J. P., Kaminski, M. S., Braziel, R. M., Spier, C. M., Gopal, A. K., Maloney, D. G., Cheson, B. D., Dakhil, S., LeBlanc, M., Smith, S. M., Fisher, R. I., Friedberg, J. W. & Press, O. W. Mar 1 2018 In : Journal of Clinical Oncology. 36, 7, p. 697-703 7 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Therapeutics
Second Primary Neoplasms
Myelodysplastic Syndromes
Acute Myeloid Leukemia

Impact of histological grading on survival in the SWOG S0016 follicular lymphoma cohort

Rimsza, L. M., Li, H., Braziel, R. M., Spier, C. M., Persky, D. O., Dunlap, J., Leblanc, M., Bartlett, N., Leonard, J. P., Smith, S. M., Press, O. W. & Friedberg, J. W. Mar 23 2018 In : Haematologica. 103, 4, p. e151-e153

Research output: Contribution to journalLetter

Follicular Lymphoma

Tandem Autologous Hematopoietic Cell Transplantation for Patients with Primary Progressive or Recurrent Hodgkin Lymphoma: A SWOG and Blood and Marrow Transplant Clinical Trials Network Phase II Trial (SWOG S0410/BMT CTN 0703)

Smith, E. P., Li, H., Friedberg, J. W., Constine, L. S., Rimsza, L. M., Cook, J. R., Laport, G. G., Popplewell, L. L., Holmberg, L. A., Smith, S. M., LeBlanc, M., Forman, S. J., Fisher, R. I. & Stiff, P. J. Jan 1 2018 (Accepted/In press) In : Biology of Blood and Marrow Transplantation.

Research output: Contribution to journalArticle

Phase II Clinical Trials
Cell Transplantation
Hodgkin Disease
Hematopoietic Stem Cells
Bone Marrow
3 Citations

Aberrant cytoplasmic expression of MHCII confers worse progression free survival in diffuse large B-cell lymphoma

Kendrick, S., Rimsza, L. M., Scott, D. W., Slack, G. W., Farinha, P., Tan, K. L., Persky, D., Puvvada, S., Connors, J. M., Sehn, L., Gascoyne, R. D. & Schmelz, M. Jan 1 2017 In : Virchows Archiv. 470, 1, p. 113-117 5 p.

Research output: Contribution to journalArticle